<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Integrated Diagnostics</title>
	<atom:link href="http://www.integrated-diagnostics.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.integrated-diagnostics.com</link>
	<description>Molecular Diagnostics, Genomics &#38; Proteomics, Systems Medicine &#38; Systems Biology</description>
	<lastBuildDate>Fri, 18 May 2012 18:49:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=</generator>
		<item>
		<title>Integrated Diagnostics® Secures $10 Million Third Tranche of Series A Financing; Company Appoints CFO and CBO, Completing Executive Team</title>
		<link>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-secures-10-million-third-tranche-of-series-a-financing-company-appoints-cfo-and-cbo-completing-executive-team/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-secures-10-million-third-tranche-of-series-a-financing-company-appoints-cfo-and-cbo-completing-executive-team/#comments</comments>
		<pubDate>Wed, 22 Feb 2012 13:02:53 +0000</pubDate>
		<dc:creator>Eliot Dobris</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.integrated-diagnostics.com/?p=1280</guid>
		<description><![CDATA[SEATTLE – Integrated Diagnostics (InDi®), an emerging leader in molecular diagnostics, today announced that the company has made substantial progress in its diagnostic programs, triggering a $10 million third tranche of its Series A financing. The company will use the funds to complete clinical development of its in vitro proteomic-based diagnostics programs and prepare for...<a href="http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-secures-10-million-third-tranche-of-series-a-financing-company-appoints-cfo-and-cbo-completing-executive-team/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-secures-10-million-third-tranche-of-series-a-financing-company-appoints-cfo-and-cbo-completing-executive-team/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Agilent Technologies and Integrated Diagnostics Enter Strategic Partnership to Develop Protein-Based Assays for Early Disease Detection</title>
		<link>http://www.integrated-diagnostics.com/press-releases/agilent-technologies-and-integrated-diagnostics-enter-strategic-partnership-to-develop-protein-basedassays-for-early-disease-detection/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/agilent-technologies-and-integrated-diagnostics-enter-strategic-partnership-to-develop-protein-basedassays-for-early-disease-detection/#comments</comments>
		<pubDate>Tue, 10 Jan 2012 08:30:44 +0000</pubDate>
		<dc:creator>Eliot Dobris</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.integrated-diagnostics.com/?p=1177</guid>
		<description><![CDATA[SANTA CLARA, Calif., and SEATTLE, Wash., – Agilent Technologies Inc. (NYSE: A) and Integrated Diagnostics today announced a strategic partnership to develop assays that detect major human diseases at very early stages to improve treatment outcomes. Integrated Diagnostics, an emerging leader in molecular diagnostics, is creating large-scale, blood-based molecular diagnostics that leverage advances in proteomics...<a href="http://www.integrated-diagnostics.com/press-releases/agilent-technologies-and-integrated-diagnostics-enter-strategic-partnership-to-develop-protein-basedassays-for-early-disease-detection/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/agilent-technologies-and-integrated-diagnostics-enter-strategic-partnership-to-develop-protein-basedassays-for-early-disease-detection/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Caltech and Integrated Diagnostics Researchers Receive Grand Challenges Point-of-Care Diagnostics Grant</title>
		<link>http://www.integrated-diagnostics.com/press-releases/caltech-and-integrated-diagnostics-researchers-receive-grand-challenges-point-of-care-diagnostics-grant/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/caltech-and-integrated-diagnostics-researchers-receive-grand-challenges-point-of-care-diagnostics-grant/#comments</comments>
		<pubDate>Fri, 16 Dec 2011 17:30:37 +0000</pubDate>
		<dc:creator>Eliot Dobris</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.integrated-diagnostics.com/?p=1157</guid>
		<description><![CDATA[SEATTLE –– Integrated Diagnostics announced today that researchers from the company and the California Institute of Technology (Caltech) will receive a Point-of-Care Diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill &#38; Melinda Gates Foundation that seeks to engage creative minds across scientific disciplines — including those who have not...<a href="http://www.integrated-diagnostics.com/press-releases/caltech-and-integrated-diagnostics-researchers-receive-grand-challenges-point-of-care-diagnostics-grant/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/caltech-and-integrated-diagnostics-researchers-receive-grand-challenges-point-of-care-diagnostics-grant/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Integrated Diagnostics and Caltech Researchers Jointly Create Synthetic Class of Diagnostics and Therapeutic Agents with Antibody-Like Properties</title>
		<link>http://www.integrated-diagnostics.com/press-releases/caltech-protein-catalyzed-capture-agents-pccs/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/caltech-protein-catalyzed-capture-agents-pccs/#comments</comments>
		<pubDate>Wed, 26 Oct 2011 10:34:55 +0000</pubDate>
		<dc:creator>Eliot Dobris</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.integrated-diagnostics.com/?p=993</guid>
		<description><![CDATA[Protein-Catalyzed Capture Agents (PCCs) Designed Using “Click Chemistry” Show Promise for Broad Use in Diagnostics and Therapeutics Data Demonstrating Synthetic Class of Site-Specific Binding Molecules is Published in the Journal of the American Chemical Society SEATTLE – Integrated Diagnostics, an emerging leader in molecular diagnostics, today announced that it has created a synthetic class of...<a href="http://www.integrated-diagnostics.com/press-releases/caltech-protein-catalyzed-capture-agents-pccs/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/caltech-protein-catalyzed-capture-agents-pccs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Integrated Diagnostics Licenses &#8220;Click Chemistry&#8221; From The Scripps Research Institute, Strengthening Partner Network</title>
		<link>http://www.integrated-diagnostics.com/press-releases/barry-sharpless-click-chemistry/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/barry-sharpless-click-chemistry/#comments</comments>
		<pubDate>Wed, 26 Oct 2011 10:28:46 +0000</pubDate>
		<dc:creator>Eliot Dobris</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.integrated-diagnostics.com/?p=988</guid>
		<description><![CDATA[Dr. Barry Sharpless, Nobel Laureate and Click Chemistry Pioneer, Joins Integrated Diagnostics as Advisor SEATTLE – Integrated Diagnostics, an emerging leader in molecular diagnostics, today announced that it has signed a worldwide licensing agreement with The Scripps Research Institute, strengthening its growing network of partners. Under the license, the company will have access to “click...<a href="http://www.integrated-diagnostics.com/press-releases/barry-sharpless-click-chemistry/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/barry-sharpless-click-chemistry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Integrated Diagnostics Appoints Jay Moyes to Board of Directors</title>
		<link>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-jay-moyes-to-board-of-directors/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-jay-moyes-to-board-of-directors/#comments</comments>
		<pubDate>Wed, 09 Mar 2011 06:00:29 +0000</pubDate>
		<dc:creator>Eliot Dobris</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://integrated-diagnostics.com/?p=817</guid>
		<description><![CDATA[Past CFO of Myriad Genetics Joins Preeminent Team at Dr. Lee Hood-Founded Molecular Diagnostics Company SEATTLE – Integrated Diagnostics, an emerging leader in molecular diagnostics founded by Lee Hood, M.D., Ph.D., today announced that Jay Moyes has joined the company&#8217;s Board as an independent director. Moyes is the past chief financial officer of Myriad Genetics...<a href="http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-jay-moyes-to-board-of-directors/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-jay-moyes-to-board-of-directors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Integrated Diagnostics Appoints Dr. Kenneth C. Fang Chief Medical Officer</title>
		<link>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-dr-kenneth-c-fang-chief-medical-officer/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-dr-kenneth-c-fang-chief-medical-officer/#comments</comments>
		<pubDate>Wed, 26 Jan 2011 03:00:15 +0000</pubDate>
		<dc:creator>Eliot Dobris</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://integrated-diagnostics.com/?p=690</guid>
		<description><![CDATA[New CMO to lead rapid development and commercialization of blood-based diagnostics for lung cancer and Alzheimer’s disease SEATTLE – Integrated Diagnostics, an emerging leader in molecular diagnostics founded by Lee Hood, M.D., Ph.D., today announced that Kenneth C. Fang, M.D., has been appointed chief medical officer and vice president of translational research and clinical development....<a href="http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-dr-kenneth-c-fang-chief-medical-officer/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-dr-kenneth-c-fang-chief-medical-officer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dr. Gregory Critchfield Joins Integrated Diagnostics Board of Directors</title>
		<link>http://www.integrated-diagnostics.com/press-releases/dr-gregory-critchfield-joins-integrated-diagnostics-board-of-directors/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/dr-gregory-critchfield-joins-integrated-diagnostics-board-of-directors/#comments</comments>
		<pubDate>Tue, 05 Oct 2010 19:06:11 +0000</pubDate>
		<dc:creator>Eliot Dobris</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://64.13.251.101/?p=369</guid>
		<description><![CDATA[Past President of Myriad Genetic Laboratories Joins Preeminent Team at Dr. Lee Hood-Founded Molecular Diagnostics Company SEATTLE – Integrated Diagnostics, an emerging leader in molecular diagnostics founded by Lee Hood, M.D., Ph.D., today announced that Gregory Critchfield, M.D., M.S., has joined the company&#8217;s Board as an independent director. Dr. Critchfield is the past president of...<a href="http://www.integrated-diagnostics.com/press-releases/dr-gregory-critchfield-joins-integrated-diagnostics-board-of-directors/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/dr-gregory-critchfield-joins-integrated-diagnostics-board-of-directors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Integrated Diagnostics Secures $10 Million Second Tranche of Series A Financing</title>
		<link>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-secures-10-million-second-tranche-of-series-a-financing/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-secures-10-million-second-tranche-of-series-a-financing/#comments</comments>
		<pubDate>Thu, 22 Jul 2010 14:06:08 +0000</pubDate>
		<dc:creator>Admin</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://64.13.251.101/?p=1</guid>
		<description><![CDATA[Substantial Progress Made in Developing Blood-Based Proteomic Diagnostics; BioTechCube Luxembourg Joins Series A Investors; New Board Member Appointed SEATTLE – Integrated Diagnostics, an emerging leader in personalized diagnostics founded by Dr. Leroy Hood, today announced that the company has made substantial progress, triggering a $10 million second tranche of its Series A financing. The funds...<a href="http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-secures-10-million-second-tranche-of-series-a-financing/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-secures-10-million-second-tranche-of-series-a-financing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Integrated Diagnostics Appoints Dr. Albert Luderer to Serve as CEO</title>
		<link>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-dr-albert-luderer-ceo/</link>
		<comments>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-dr-albert-luderer-ceo/#comments</comments>
		<pubDate>Mon, 29 Mar 2010 11:41:13 +0000</pubDate>
		<dc:creator>Admin</dc:creator>
				<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://64.13.251.101/?p=224</guid>
		<description><![CDATA[Senior Life Sciences Executive Will Lead Emerging Personalized Diagnostics Company Founded by Dr. Leroy Hood SEATTLE – Integrated Diagnostics, a personalized diagnostics company founded by Dr. Leroy Hood, today announced that Dr. Albert Luderer has been appointed by the Board of Directors to serve as CEO. Dr. Luderer was previously president and CEO of BioTrove,...<a href="http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-dr-albert-luderer-ceo/"> more</a>]]></description>
		<wfw:commentRss>http://www.integrated-diagnostics.com/press-releases/integrated-diagnostics-appoints-dr-albert-luderer-ceo/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

